6-Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel)

被引：49

作者：

Didier, Romain ^{[1
]}

Morice, Marie Claude ^{[2
]}

Barragan, Paul ^{[3
]}

Noryani, Arif A. L. ^{[4
]}

Noor, Hussam A. ^{[5
]}

Majwal, Talib ^{[6
]}

Hovasse, Thomas ^{[2
]}

Castellant, Philippe ^{[1
]}

Schneeberger, Michel ^{[7
]}

Maillard, Luc ^{[8
]}

Bressolette, Erwan ^{[9
]}

Wojcik, Jaroslaw ^{[10
]}

Delarche, Nicolas ^{[11
]}

Blanchard, Didier ^{[12
]}

Jouve, Bernard ^{[13
]}

Ormezzano, Olivier ^{[14
]}

Paganelli, Franck ^{[15
]}

Levy, Gilles ^{[16
]}

Sainsous, Joel ^{[17
]}

Carrie, Didier ^{[18
]}

Furber, Alain ^{[19
]}

Berlan, Jacques ^{[20
]}

Darremont, Olivier ^{[21
]}

Le Breton, Herve ^{[22
]}

Lyuycx-Bore, Anne ^{[23
]}

Gommeaux, Antoine ^{[24
]}

Cassat, Claude ^{[25
]}

Kermarrec, Alain ^{[26
]}

Cazaux, Pierre ^{[27
]}

Druelles, Philippe ^{[28
]}

Dauphin, Raphael ^{[29
]}

Armengaud, Jean ^{[30
]}

Dupouy, Patrick ^{[31
]}

Champagnac, Didier ^{[32
]}

Ohlmann, Patrick ^{[33
]}

Ben Amer, Hakim ^{[34
]}

Kiss, Robert G. ^{[35
]}

Ungi, Irme ^{[36
]}

Gilard, Martine ^{[1
]}

机构：

[1] Brest Univ, Dept Cardiol, Brest, France

[2] ICPS, Massy, France

[3] Clin Fleurs, Ollioules, France

[4] Al Qassimi Hosp, Sharjah, U Arab Emirates

[5] Bahrain Def Force, West Riffa, Bahrain

[6] Dubai Hosp, Dubai, U Arab Emirates

[7] Hop Albert Schweitzer, Colmar, France

[8] Clin Axium, Aix En Provence, France

[9] NCN, Nantes, France

[10] Klin Kardiol SPSK4, Lublin, Poland

[11] CH Mitterrand, Pau, France

[12] Clin St Gatien, Tours, France

[13] CH Aix en Provence, Aix En Provence, France

[14] CHU Grenoble, Grenoble, France

[15] CHU Hop Nord, Marseille, France

[16] Clin Millenaire, Montpellier, France

[17] Clin Rhone Durance, Avignon, France

[18] CHU, Toulouse, France

[19] CHU Angers, Angers, France

[20] Clin St Hilaire, Rouen, France

[21] Clin St Augustin, Bordeaux, France

[22] CHU, Rennes, France

[23] CH Compiegne, Compiegne, France

[24] Polyclin Bois, Bernard, France

[25] CHU, Limoges, France

[26] CH Vannes, Vannes, France

[27] CH Lorient, Lorient, France

[28] Poly St Laurent, Rennes, France

[29] Hop Croix Rousse, Lyon, France

[30] Clin Esquirol, Agen, France

[31] Hop Prive, Antony, France

[32] Clin Tonkin, Villeurbanne, France

[33] CHU Strasbourg, Strasbourg, France

[34] Hop Roseraie, Aubervilliers, France

[35] Honved Korhaz, Budapest, Hungary

[36] SZTE Szent Gyorgyi Albert, Szeged, Hungary

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2017年 / 10卷 / 12期

关键词：

drug-eluting stent(s); dual antiplatelet therapy; percutaneous coronary intervention; MYOCARDIAL-INFARCTION; TASK-FORCE; DURATION; ASSOCIATION; GUIDELINES; THROMBOSIS; EFFICACY; SOCIETY; 6-MONTH; SAFETY;

D O I：

10.1016/j.jcin.2017.03.049

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVES The aim of this study was to test the hypothesis that 6-month dual antiplatelet therapy (DAPT) is non-inferior to 24-month DAPT in aspirin-sensitive patients. BACKGROUND The ITALIC (Is There a Life for DES After Discontinuation of Clopidogrel) trial showed that rates of bleeding and thrombotic events at 1 year were much the same with 6 versus 12 months of DAPT after percutaneous coronary intervention with second-generation drug-eluting stents. In this report, 2-year follow-up is presented. METHODS In a multicenter randomized study, patients with confirmed nonresistance to aspirin undergoing drug-eluting stent implantation were allocated to 6 or 24 months of DAPT. The primary endpoint was a composite of death, myocardial infarction, urgent target vessel revascularization, stroke, and major bleeding at 12 months post-percutaneous coronary intervention. The secondary endpoints comprised the same composite endpoint at 24 months and each individual component. RESULTS Overall, 2,031 patients from 70 centers were screened; 926 were randomized to 6-month and 924 to 24-month DAPT. Noninferiority was demonstrated for 6-versus 12-month DAPT, with an absolute risk difference of 0.11% (95% confidence interval: -1.04% to 1.26%; p = 0.0002). At 2 years, the composite endpoint was unchanged, at 3.5% for 6 months and 3.7% for 24 months (p = 0.79), and rates of myocardial infarction (1.3% vs. 1.0%; p = 0.51), stroke (0.6% vs. 0.8%; p = 0.77), and target vessel revascularization (1.0% vs. 0.3%; p = 0.09) were likewise similar. There was a trend toward higher mortality with longer DAPT (2.2% vs. 1.2%; p = 0.11). Four patients (0.4%) in the 24-month group and none in the 6-month group had major bleeding. CONCLUSIONS Two-year outcomes in the ITALIC trial confirmed the 1-year results and showed that patients receiving 6-month DAPT after percutaneous coronary intervention with second-generation drug-eluting stent have similar outcomes to those receiving 24-month DAPT. (C) 2017 by the American College of Cardiology Foundation.

引用

页码：1202 / 1210

页数：9

共 27 条

[1] Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].

Airoldi, Flavio ;

Colombo, Antonio ;

Morici, Nuccia ;

Latib, Azeem ;

Cosgrave, John ;

Buellesfeld, Lutz ;

Bonizzoni, Erminio ;

Carlino, Mauro ;

Gerckens, Ulrich ;

Godino, Cosmo ;

Melzi, Gloria ;

Michev, Iassen ;

Montorfano, Matteo ;

Sangiorgi, Giuseppe Massimo ;

Qasim, Asif ;

Chieffo, Alaide ;

Briguori, Carlo ;

Grube, Eberhard .

CIRCULATION, 2007, 116 (07) :745-754

[2] Mechanisms of Plaque Formation and Rupture [J].

Bentzon, Jacob Fog ;

Otsuka, Fumiyuki ;

Virmani, Renu ;

Falk, Erling .

CIRCULATION RESEARCH, 2014, 114 (12) :1852-1866

[3] Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction [J].

Bonaca, Marc P. ;

Bhatt, Deepak L. ;

Cohen, Marc ;

Steg, Philippe Gabriel ;

Storey, Robert F. ;

Jensen, Eva C. ;

Magnani, Giulia ;

Bansilal, Sameer ;

Fish, M. Polly ;

Im, Kyungah ;

Bengtsson, Olof ;

Ophuis, Ton Oude ;

Budaj, Andrzej ;

Theroux, Pierre ;

Ruda, Mikhail ;

Hamm, Christian ;

Goto, Shinya ;

Spinar, Jindrich ;

Nicolau, Jose Carlos ;

Kiss, Robert G. ;

Murphy, Sabina A. ;

Wiviott, Stephen D. ;

Held, Peter ;

Braunwald, Eugene ;

Sabatine, Marc S. ;

Morin, Suzanne ;

Dantzer, Emily ;

Acquilano, Dayle ;

McGuire, Rachael L. ;

Gannon, Joseph B. ;

Gershman, Elaine ;

Ahlbom, Ann Maxe ;

Boberg, Barbro ;

Abola, Maria Teresa ;

Ardissino, Diego ;

Aylward, Philip ;

Corbalan, Ramon ;

Dalby, Anthony ;

Diaz, Rafael ;

Hu, Dayi ;

Isaza, Daniel ;

Kamensky, Gabriel ;

Kiss, Robert ;

Kontny, Frederic ;

Lopez-Sendon, Jose ;

Medina, Felix ;

Montalescot, Gilles ;

Nicolau, Jose ;

Paolasso, Ernesto ;

Parkhomenko, Alexander .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19) :1791-1800

[4] HEMORRHAGIC EVENTS DURING THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, HEPARIN, AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI), PHASE-II TRIAL [J].

BOVILL, EG ;

TERRIN, ML ;

STUMP, DC ;

BERKE, AD ;

FREDERICK, M ;

COLLEN, D ;

FEIT, F ;

GORE, JM ;

HILLIS, LD ;

LAMBREW, CT ;

LEIBOFF, R ;

MANN, KG ;

MARKIS, JE ;

PRATT, CM ;

SHARKEY, SW ;

SOPKO, G ;

TRACY, RP ;

CHESEBRO, JH .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (04) :256-265

[5] Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial [J].

Collet, Jean-Philippe ;

Silvain, Johanne ;

Barthelemy, Olivier ;

Range, Gregoire ;

Cayla, Guillaume ;

Van Belle, Eric ;

Cuisset, Thomas ;

Elhadad, Simon ;

Schiele, Francois ;

Lhoest, Nicolas ;

Ohlmann, Patrick ;

Carrie, Didier ;

Rousseau, Helene ;

Aubry, Pierre ;

Monsegu, Jacques ;

Sabouret, Pierre ;

O'Connor, Stephen A. ;

Abtan, Jeremie ;

Kerneis, Mathieu ;

Saint-Etienne, Christophe ;

Beygui, Farzin ;

Vicaut, Eric ;

Montalescot, Gilles .

LANCET, 2014, 384 (9954) :1577-1585

[6] Second-Generation Drug-Eluting Stent Implantation Followed by 6-Versus 12-Month Dual Antiplatelet Therapy The SECURITY Randomized Clinical Trial [J].

Colombo, Antonio ;

Chieffo, Alaide ;

Frasheri, Arian ;

Garbo, Roberto ;

Masotti-Centol, Monica ;

Salvatella, Neus ;

Dominguez, Juan Francisco Oteo ;

Steffanon, Luigi ;

Tarantini, Giuseppe ;

Presbitero, Patrizia ;

Menozzi, Alberto ;

Pucci, Edoardo ;

Mauri, Josepa ;

Cesana, Bruno Mario ;

Giustino, Gennaro ;

Sardella, Gennaro .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (20) :2086-2097

[7] Clinical end points in coronary stent trials - A case for standardized definitions [J].

Cutlip, Donald E. ;

Windecker, Stephan ;

Mehran, Roxana ;

Boam, Ashley ;

Cohen, David J. ;

van Es, Gerrit-Anne ;

Steg, P. Gabriel ;

Morel, Marie-angele ;

Mauri, Laura ;

Vranckx, Pascal ;

McFadden, Eugene ;

Lansky, Alexandra ;

Hamon, Martial ;

Krucoff, Mitchell W. ;

Serruys, Patrick W. .

CIRCULATION, 2007, 115 (17) :2344-2351

[8] Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].

Daemen, Joost ;

Wenaweser, Peter ;

Tsuchida, Keiichi ;

Abrecht, Linda ;

Sophia, Vaina ;

Morger, Cyrill ;

Kukreja, Neville ;

Jueni, Peter ;

Sianos, Georgios ;

Hellige, Gerrit ;

van Domburg, Ron T. ;

Hess, Otto M. ;

Boersma, Eric ;

Meier, Bernhard ;

Windecker, Stephan ;

Serruys, Patrick W. .

LANCET, 2007, 369 (9562) :667-678

[9] Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial [J].

Feres, Fausto ;

Costa, Ricardo A. ;

Abizaid, Alexandre ;

Leon, Martin B. ;

Marin-Neto, J. Antonio ;

Botelho, Roberto V. ;

King, Spencer B., III ;

Negoita, Manuela ;

Liu, Minglei ;

de Paula, J. Eduardo T. ;

Mangione, Jose A. ;

Meireles, George X. ;

Castello, Helio J., Jr. ;

Nicolela, Eduardo L., Jr. ;

Perin, Marco A. ;

Devito, Fernando S. ;

Labrunie, Andre ;

Salvadori, Decio, Jr. ;

Gusmao, Marcos ;

Staico, Rodolfo ;

Costa, J. Ribamar ;

de Castro, Juliana P. ;

Abizaid, Andrea S. ;

Bhatt, Deepak L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23) :2510-2522

[10] Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials [J].

Gargiulo, Giuseppe ;

Windecker, Stephan ;

da Costa, Bruno R. ;

Feres, Fausto ;

Hong, Myeong-Ki ;

Gilard, Martine ;

Kim, Hyo-Soo ;

Colombo, Antonio ;

Bhatt, Deepak L. ;

Kim, Byeong-Keuk ;

Morice, Marie-Claude ;

Park, Kyung Woo ;

Chieffo, Alaide ;

Palmerini, Tullio ;

Stone, Gregg W. ;

Valgimigli, Marco .

BMJ-BRITISH MEDICAL JOURNAL, 2016, 355

← 1 2 3 →